The Ride presents over $400,000 to 2019 Ride Scholars
Saturday, January 18, 2020
Madison, Wis. –
Dr. Shigeki Miyamoto, a professor of oncology at the University of Wisconsin School of Medicine and Public Health, was awarded The Ride Scholarship on January 18, 2020 at the Wisconsin Hockey’s 4th Annual Face-off Against Cancer game for his exemplary discoveries in 2019. This award will help fund Dr. Miyamoto’s further research aimed at developing a biomarker for treatment resistance in multiple myeloma at the University of Wisconsin Madison.
Multiple myeloma is an incurable blood cancer with a median survival of five to seven years from diagnosis. Recently developed therapies have benefited the majority of multiple myeloma patients, but the response duration is short for nearly 25 percent of patients. Currently, there are no biomarkers that can predict multiple myeloma patients’ response to therapy and no effective therapies for patients with intractable disease.
Dr. Miyamoto and his team recently discovered a drug resistance factor in multiple myeloma patients called HAPLN1. With funding from The Ride, they will develop a method to accurately quantify HAPLN1 in multiple myeloma patients and begin to test how its level corresponds to treatment response. Ultimately, this study will help in the development of a biomarker to identify patients whose multiple myeloma does not respond well to treatment and who may benefit from an HAPLN1-targeting drug that is also being developed in the Miyamoto Lab.
The Ride was created in 2016 and has generated over $1.2 Million towards the University of Wisconsin’s cancer mission. The Ride delivers 100% of all rider-raised funds towards cancer initiatives made possible by the generous support of its sponsors.
Participants have the ability to register for any of the five routes (3-mile, 17-mile, 34-mile, 63-mile, 102-mile) which feature the same start and finish location. The 3-mile route, which caters to adults and children will be solely contained within the American Family Insurance campus and will not utilize any public roads. In addition, the new site location and layout will offer increased participant on-site amenities such as parking, registration, packet pick-up, food and post-ride programming and entertainment.
Visit TheRideWI.org to learn more about the cycling benefit and how it drives critical cancer research and treatment programs at the University of Wisconsin.